Cochin Hospital
Paris, 75014, France
Location status: Recruiting
NCT Number: NCT06133426
In this research, we will evaluate the feasibility of following by remote monitoring, using a connected scale, in hematology patients suffering from myeloma or lymphoma and requiring treatment with chemotherapy. 30 patients will be included in the research and will all use a connected scale for the duration of their participation (7 weeks +/- 1 week). During their participation, patients will be asked to weigh themselves once a day, ideally at a set time. Patient data will be accessible by the medical team via a remote monitoring platform.
Alerts will be generated in the event of abnormal development of certain clinical parameters (weight, heart rate, etc.) allowing early treatment to be implemented by the medical team.
At the end of their participation, we will evaluate patients' support and perception of this tool, as well as the healthcare consequences of the alerts generated by the remote monitoring platform.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Paris, 75014, France
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Use once a day from inclusion to week 7.
Time frame: Inclusion
Number of included patients / Number of indormed patients
Time frame: From inclusion to week 7
Average of weighings/week
Time frame: week 7
Specific 5 points Likert Scale (1 - 5 ; Higher score mean a worse outcome)
Time frame: week 7
Symptom Usability Scale (0 - 100 ; Higher score mean a better outcome)
Time frame: week 7
FIM (Feasibility of Intervention Measure), AIM (Acceptability of Intervention Measure) and IAM (Intervention Appropriateness Measure) / (1 - 5 ; Higher score mean a better outcome)
Time frame: From inclusion to week 7
Number of alerts generated/patient.
Time frame: From inclusion to week 7
Number of calls made/patient.
Time frame: From inclusion to week 7
Average time spent per call following the generation of an alert.
Time frame: From inclusion to week 7
Number and type of consultations, hospitalizations, additional assessments resulting from the generation of an alert.
Contact information is provided by the study sponsor or research team.
Assistance Publique - Hôpitaux de Paris
Other
Acronym: BTP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01676805
Blood Protein Disorders, Cardiovascular Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT02682667
Blood Protein Disorders, Bronchial Neoplasms
Bethesda, Maryland, United States
View Trial DetailsNCT02693535
Advanced Solid Tumors, Blood Protein Disorders
Birmingham, Alabama, United States
View Trial DetailsNCT03297606
Advanced Solid Tumors, Blood Protein Disorders
Edmonton, Alberta, Canada
View Trial Details